A novel blood test designed for speedier diagnosis of a debilitating illness that affects tens of millions of people worldwide shows potential for accurately detecting myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), according to a recent study published in Advanced Science.
The single-cell Raman spectroscopy method successfully determined disease presence and severity in close to 100 study participants with 91 percent accuracy.
